🇺🇸 FDA
Patent

US 10668279

Miniminally invasive dermal electroporation device

granted A61KA61K2039/53

Quick answer

US patent 10668279 (Miniminally invasive dermal electroporation device) held by Inovio Pharmaceuticals, Inc. expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/53